• We studied the differential effects of repetitive magnetic stimulation.
a b s t r a c t
Repetitive magnetic stimulation is a neuropsychiatric and neurorehabilitation tool that can be used to investigate the neurobiology of sensory and motor functions. Few studies have examined the effects of repetitive magnetic stimulation on the modulation of neurotrophic/growth factors and neuronal cells in vitro. Therefore, the current study examined the differential effects of repetitive magnetic stimulation on neuronal cell proliferation as well as various growth factor expression. Immortalized mouse neuroblastoma cells were used as the cell model in this study. Dishes of cultured cells were randomly divided into control, sham, low-frequency (0.5 Hz, 1 Tesla) and high-frequency (10 Hz, 1 Tesla) groups (n = 4 dishes/group) and were stimulated for 3 days. Expression of neurotrophic/growth factors, Akt and Erk was investigated by Western blotting analysis 3 days after repetitive magnetic stimulation. Neuroblastoma cell proliferation was determined with a cell counting assay. There were differences in cell proliferation based on stimulus frequency. Low-frequency stimulation did not alter proliferation relative to the control, while high-frequency stimulation elevated proliferation relative to the control group. The expression levels of brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), neurotrophin-3 (NT-3) and platelet-derived growth factor (PDGF) were elevated in the high-frequency magnetic stimulation group. Akt and Erk expression was also significantly elevated in the high-frequency stimulation group, while low-frequency stimulation decreased the expression of Akt and Erk compared to the control. In conclusion, we determined that different frequency magnetic stimulation had an influence on neuronal cell proliferation via regulation of Akt and ERK signaling pathways and the expression of growth factors such as BDNF, GDNF, NT-3 and PDGF. These findings represent a promising opportunity to gain insight into how different frequencies of repetitive magnetic stimulation may mediate cell proliferation.
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Introduction
Transcranial magnetic stimulation is based on electromagnetic induction, which was initially observed by Michael Faraday almost 200 years ago [1] . A transcranial magnetic stimulator with a coil can produce a short 100 ms biphasic electromagnetic pulse, which generates an electric current in the central nervous system (CNS) [2] . The resulting magnetic field induces electrical current in nervous tissue and, at sufficient strength, produces neuronal depolarization [3] . When administered at regular frequencies, this process is referred to as 'repetitive transcranial magnetic stimulation' or 'rTMS' [4] . rTMS has been used to treat CNS diseases because it non-invasively stimulates brain areas, and also has less pain and fewer side-effects than other treatments [3, 5] . rTMS is a neuropsychiatric and neurorehabilitation tool [4, 6, 7] that can be used to investigate the neurobiology of sensory and motor functions [6, 8, 9] . High-frequency (>3 Hz) stimulation generally results in facilitation, while low-frequency (<1 Hz) rTMS induces reduction of synaptic efficiency [10] . Based on this mechanism, several clinical trials have revealed that rTMS provides kinetic function improvements and change neurotransmitter system [6, 7, 11, 12] . Additionally, other studies have reported that rTMS affects neural stem cell proliferation in the subventricular zone [13] . However, few studies have examined the in vitro and in vivo effects of repetitive magnetic stimulation. The effects of stimulation in different frequencies also remain uncertain. Therefore, we examined changes in cell proliferation and expression of growth factors in mouse neuroblastoma cells.
Materials and methods

Cell cultures
The immortalized mouse neuroblastoma cell line N1E-115 (ATCC ® CRL-2263 TM ), which expresses normal neuronal phenotypes, was used as a cell model in this study. Mouse neuroblastoma cells were seeded at 2 × 10 5 cells/cm 2 in 100 culture dish in Dulbecco's Modified Eagle Medium without pyruvate (DMEM; Invitrogen-Gibco, Rockville, MD, USA) but containing 10% fetal bovine serum (FBS; Invitrogen-Gibco) and 100 U/ml penicillin/streptomycin (Invitrogen-Gibco) in a humidified 5% CO 2 atmosphere at 37 • C. The media was replaced at three day intervals. Neuroblastoma cells were subcultured when they reached 80-90% confluence. The numbers of neuroblastoma cells were counted using the manual hemocytometer method.
Repetitive magnetic stimulation
Dishes of cultured cells were randomly allocated into the following three groups: untreated controls (n = 4), low-frequency (0.5 Hz) stimulation group (n = 4), and high-frequency (10 Hz) stimulation group (n = 4). Briefly, the coil was placed above a single dish (one dish per treatment group), and its center was aligned with the center of the dish; the distance between the dimensional center of the coil and the culture dish was 1.0 cm. The repetitive magnetic stimulation was performed with 0.5 Hz and 10 Hz frequencies (on-off interval, 3 s), with a 100% machine output stimulation intensity at a stimulation duration of 20 min per day. The treatments were performed daily for 3 days. Control neurons were handled in a similar manner to the treatment group exposed to the magnetic stimulation apparatus for the identical length of time but was shielded by Mu metal, therefore did not receive any stimulation.
Western blotting
To compare the expression levels of neurotrophic factors, neuroblastoma cells (n = 4 per group) were lysed in 300 l of cold RIPA buffer (50 mM Tris-HCl, pH 7.5, 1% Triton X-100, 150 mM NaCl, 0.1% sodium dodecyl sulfate (SDS), and 1% sodium deoxycholate) with a protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO, USA). Cells lysate was centrifuged at 13,000 × g for 15 min at 4 • C. The supernatant was harvested, and protein concentration was analyzed using a Qunt-iT protein assay kit (Molecular Probes, Eugene, Oregon, USA). For electrophoresis, 50 g of protein was dissolved in a sample buffer (60 mM Tris-HCl, pH 6.8, 14.4 mM ␤-mercaptoethanol, 25% glycerol, 2% SDS, and 0.1% bromophenol blue), boiled for 10 min and separated on a 10% SDS reducing gel. Separated proteins were transferred onto polyvinylidene difluoride (PVDF) membranes (Invitrogen, Carlsbad, CA) using a trans-blot system. Blots were blocked for 1 h in Tris-buffered saline (TBS) (10 mM Tris-HCl, pH 7.5, 150 mM NaCl) containing 5% nonfat dry milk at room temperature, washed three times with TBS and incubated at 4 • C overnight with an anti-rabbit polyclonal brain-derived neurotrophic factor (BDNF, 1:1000, Abcam, Cambridge, MA, USA), anti-rabbit glial cell-derived neurotrophic factor (GDNF, 1:1000, Abcam), anti-rabbit neurotrophin-3 (NT-3, 1:1000; Abcam), antirabbit platelet-derived growth factor (PDGF, 1:1000; Abcam), and anti-␤ actin (1:3000, Cell signaling, Boston, MA, USA) antibody in TBST (10 mM Tris, pH 7.5, 150 mM NaCl, and 0.02% Tween 20) containing 5% nonfat dry milk. On the next day, blots were washed three times with TBST and incubated for 1 h at room temperature with horseradish peroxidase-conjugated secondary antibodies (1:3000, Santa Cruz Biotech, Santa Cruz, CA, USA) in TBST containing 3% nonfat dry milk. After washing three times with TBST, proteins were visualized with an ECL detection system (Amersham Pharmacia Biotech, Piscataway, NJ, USA).
Blockage of growth factors
To determine the relation between growth factors and cell proliferation, we used NT-3, GDNF and PDGF blocking peptide. Mouse neuroblastoma cells were seeded at a density of 1 × 10 6 cells/cm 2 in 100 culture dish. After 24 h, cells were washed with Dulbecco's phosphate buffered saline (DPBS; Invitrogen-Gibco) five times, and media were replaced with serum-free media containing 2 g/ml NT-3 blocking peptide (Santa Cruz Biotech), GDNF blocking peptide (Biovision, CA, USA) and PDGF blocking peptide (Santa Cruz Biotech). Cells were incubated with or without growth factor blocking peptides for 12 h. The cells were then treated rTMS stimulation with 0.5 Hz and 10 Hz daily for 3 days.
Statistical analysis
Results shown in the bar graphs are the mean ± SE of at least 4 independent experiments. Statistical analysis of cell proliferation was performed in untreated, 0.5 Hz and 10 Hz stimulation groups using t-test and analysis of variance (ANOVA) with post hoc Bonferroni comparison. A P-value <0.05 was considered statistically significant.
Results
Immunoblot analysis of neuronal growth factors
To identify the growth factors associated with the functional recovery repair process and the neuroprotective and/or neurorestorative effects induced by repetitive magnetic stimulation, the expressions of various neurotrophic/growth factors including BDNF, GDNF, NT-3, and PDGF were investigated using Western blot analysis (Fig. 1) . The level of BDNF was significantly elevated in the high-frequency stimulation group (10 Hz) compared with the low-frequency stimulation group (0.5 Hz) and the non-treatment group (Fig. 1B) (p < 0.01, F = 14.19). The level of GDNF was significantly elevated in the high-frequency stimulation group (10 Hz) compared with the low-frequency stimulation group (0.5 Hz) and the non-treatment group (Fig. 1C) (p < 0.01, F = 15.07). The level of NT-3 was significantly elevated in the high-frequency stimulation group (10 Hz) compared with the low-frequency stimulation group (0.5 Hz) and the non-treatment group (Fig. 1D) (p < 0.01, F = 12.64). The level of PDGF was significantly elevated in the high-frequency stimulation group (10 Hz) compared with the low-frequency stimulation group (0.5 Hz) and the untreated group (Fig. 1E) (p < 0.001, F = 114.1).
High frequency stimulation increased ERK and Akt expression
Our study showed that repetitive magnetic stimulation changed the expression of signaling cascades including ERK and Akt related to the neurotrophic/growth factors, which are associated with cell survival and proliferation. Akt and ERK were investigated using the Western blot analysis (Fig. 2) . The Akt protein expression was significantly increased in the high-frequency stimulation group compared with the control and low-frequency group (p < 0.001, F = 85.19). But the level of Akt protein significantly decreased in the low-frequency group compared to the control group (p < 0.001) (Fig. 2B) . The level of ERK protein was significantly increased in the high-frequency stimulation group compared with the control and low-frequency stimulation group (p < 0.001, F = 12.64), while low-frequency stimulation significantly decreased the level of ERK protein compared with only high-frequency stimulation (p < 0.0001).
Neuroblastoma cell proliferation after repetitive magnetic stimulation
Repetitive magnetic stimulation (circular coil, 100% of motor threshold, 20 min/day) was used to treat mouse neuroblastoma cells for 4 days. Following the untreated and 0.5 Hz stimulation treatment, the number of neuroblastoma cells significantly decreased at 4 days. In contrast, the number of neuroblastoma cells significantly increased in the 10 Hz stimulation group (Fig. 3A) . Compared to the corresponding untreated and the lowfrequency stimulation treated neuroblastoma cells, proliferation rates of 10 Hz treated cells were 487% at 4 days. The number of cells of the high-frequency group was significantly higher (4.05 × 10 5 ± 25000) than the control group (8.3 × 10 4 ± 3000). However, the number of cells were not significantly different between the low-frequency group (6.75 × 10 4 ± 12500) and the untreated group (8.3 × 10 4 ± 3000) at 4 days post-treatment (Table 1 and Fig. 2 ) (p < 0.01). The proliferation effect of repetitive magnetic stimulation was confirmed only in the high-frequency stimulation group (Fig. 3B ).
Discussion
rTMS is now well-established that high-frequency stimulation increases human cortical excitability for minutes to even hours beyond the stimulation period [14] . Depending on the stimulation frequency, rTMS is able to temporarily modulate cortical excitability and produce consistent, long-lasting effects on physiology within the cortex [15] . However, the previous study did not clarify the effect on regulation of various growth factors and cellular and molecular changes by its different frequencies in vitro. Therefore, the purpose of this study was to provide 
Table 1
The number of neuroblastoma cells after repetitive magnetic stimulation.
Control (untreated)
Low-frequency (0.5 Hz) High-frequency (10 Hz)
Mouse neuroblastoma cells 8.3 × 10 4 ± 3000 6.75 × 10 4 ± 12500 4.05 × 10 5 ± 25000
Values are mean ± SEM.
experimental evidence that in vitro repetitive magnetic stimulation induces neuroblastoma cell proliferation and growth factors following low-frequency (0.5 Hz) and high-frequency (10 Hz) stimulation. This study examined the changes in expression of BDNF, GDNF, NT-3 and PDGF, and cell proliferation in immortalized mouse neuroblastoma cells. Neurotrophic/growth factor results showed that highfrequency stimulation increased expression of BDNF. This result is in concordance with recent literature that assumes high-frequency magnetic stimulation induces the BDNF signaling pathway [10, 11, 16] . While low-frequency stimulation decreased expression of BDNF in neuroblastoma cells, this result conflicted with previous studies in rats and humans. However, due to insufficient results further studies are required to confirm our findings. Our results also demonstrated that high-frequency stimulation increased the levels of GDNF, NT3 and PDGF in neuronal cells, while low-frequency stimulation did not facilitate or decrease expression of GDNF, NT-3, and PDGF in target cells. These results may be the first to demonstrate that different frequencies of repetitive magnetic stimulation regulate GNDF, NT-3 and PDGF in neuroblastoma cells. In addition, this study examined the changes in expression of signaling cascades related to cell proliferation, such as the Akt and Erk protein as well as neurotrophic and growth factors. Akt and Erk are well known signaling cascades which transmits survival signals from growth factors to regulate cell survival and proliferation [17, 18] .
In this study, we investigated the effects of different frequencies of repetitive magnetic stimulation on cell proliferation. We demonstrated that high-frequency stimulation significantly increased proliferation in neuroblastoma cells, while low-frequency stimulation decreased cell proliferation. This study showed that repetitive magnetic stimulation activated or inactivated signaling pathways associated with cell proliferation and growth factor expression. It seems that repetitive magnetic stimulation modulates intracellular signaling or gene expression, as well as synaptic activity and/or mediating inter-hemispheric balance of neural activity. Particularly, high-frequency stimulation increased four growth factors such as BDNF, GDNF, NT3, and PDGF and activated the Akt and Erk signaling cascades in neuroblastoma cells.
Neurotrophins/growth factors such as BDNF and NT-3 regulate synaptic strength and thereby mediate plasticity. Moreover, ample evidence supports an important role of BDNF, GDNF, NT3, and PDGF in the survival, development, differentiation, and regeneration of neurons [19, 20, 21, 22] , as well as in synaptic transmission and plasticity [23, 24] . In a previous study [11] , high-frequency stimulation significantly increased expression of various growth factors (BDNF, GDNF, NGF, PDGF, and VEGF) associated with the repair process of functional recovery and the neuroprotective and/or neurorestorative effects in an animal model with Parkinson's disease. Considering our results, high-frequency stimulation increased expression of various growth factors and Akt and Erk related to proliferation and survival, causing increased proliferation in neuroblastoma cells.
In this study, we proposed the repetitive magnetic stimulation effects on cell proliferation are mediated by growth factors. When we treated anti-growth factor blockers on neuroblast cells, and then treated with repetitive magnetic stimulation with different frequencies, the number of cells decreased in the NT-3-, GDNF-, and PDGF-blocked cell groups, suggesting that blockage of growth factors reduced cell proliferation induced by repetitive magnetic stimulation (Fig. S1 ). There is evidence about the effect of growth factors with their downstream signaling cascade such as Akt and Erk on cell proliferation [21] . Our results also demonstrated that the effect of cell proliferation following repetitive magnetic stimulation might be mediated via action of growth factors.
As a limitation to this study, the mechanism of repetitive magnetic stimulation using variable frequencies was not elucidated in the cellular/molecular study. This is the first in vitro study of the expression of various growth factors and cell proliferation following repetitive magnetic stimulation with different frequencies. Many reports demonstrated that high frequency stimulation excited synaptic activation, and low frequency stimulation inhibited synaptic activation in human studies [3, 4, 5, 6] . Previous studies also suggested that high or low frequency stimulation activated signaling pathways, such as the BDNF-TrkB, MAPK/ErK, and PI3K/Akt pathways to upregulate expression of the downstream effector molecules and synaptic protein and neurogenesis [1, 10, 13, 16, 17] . As the mechanism of repetitive magnetic stimulation using different frequencies is still uncertain, further studies are needed to elucidate cellular and molecular mechanisms.
Another limitation of this study is that we did not use the neurosphere from SVZ. In this study, we used the mouse neuroblastoma cells (NIE115) that have been shown to be a suitable cell line for the research of neuronal differentiation, neurotransmitter release, and cellular and molecular mechanisms of neuron properties. To determine the expression of growth factors and signaling cascades by repetitive magnetic stimulation, we used the NIE115 cells. However, a study using the neurosphere from SVZ can provide more clinically important results. Therefore, further study is needed to elucidate the effects of repetitive magnetic stimulations using the neurosphere from SVZ.
In summary, our study provides evidence that different frequencies of repetitive magnetic stimulation differentially modulate neuroblastoma cell proliferation and growth factor expression. Although the result of this study may provide a novel and also valuable theoretical background for clinical applications of repetitive magnetic stimulation, further investigation is needed to elucidate the exact underlying mechanism.
Conclusion
Our results provide evidence that different frequencies of repetitive magnetic stimulation modulate growth factor expression and neuroblastoma cell proliferation in different ways. To our knowledge, these findings may be the first to demonstrate differential effects of repetitive magnetic stimulation on the expression of Akt and Erk, as well as various growth factors such as BDNF, GDNF, NT3, and PDGF, and even neuronal cell proliferation. These results of repetitive magnetic stimulation may provide a foundation for additional clinical studies.
